Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Bristol Myers Squibb announced a $2.3 billion investment to build a state-of-the-art manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. The 600,000 square foot facility will feature modular, multi-modal capabilities to produce small molecules, biologics, and antibody-drug conjugates, supporting drug manufacturing from development through launch. This expansion is part of BMS’ broader $40 billion commitment to U.S.
Key figures
- Deal Value Usd
- $2.3 billion
- Jobs created
- nearly 500
- Us commitment
- $40 billion
- Construction jobs
- approximately 2,000
- Rd investment 2025
- $10 billion
- Campus square footage
- 600000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.